Du Y - Search Results

1

Lipopolysaccharide/Toll-like receptor 4 signaling pathway involved Qingdu decoction treating severe liver injury merging with endotoxemia.

Cao W, Du Y, Gao L, Che N, Zhang Q, Luo J, Cao W, Fu X, Wang R. Cao W, et al. Among authors: du y. J Tradit Chin Med. 2017 Jun;37(3):371-377. J Tradit Chin Med. 2017. PMID: 31682380 Free article.

2

Efficacy of decoction from Jieduan Niwan formula on rat model of acute-on-chronic liver failure induced by porcine serum.

Li J, Zhang Q, Gao L, Du Y, Chen Y. Li J, et al. Among authors: du y. J Tradit Chin Med. 2020 Aug;40(4):602-612. doi: 10.19852/j.cnki.jtcm.2020.04.009. J Tradit Chin Med. 2020. PMID: 32744027 Free article.

3

Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure.

Liang J, Wu M, Bai C, Ma C, Fang P, Hou W, Wei X, Zhang Q, Du Y. Liang J, et al. Among authors: du y. Evid Based Complement Alternat Med. 2020 Dec 30;2020:1041307. doi: 10.1155/2020/1041307. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33456481 Free PMC article.

4

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury.

Ma C, Zhao M, Du Y, Jin S, Wu X, Zou H, Zhang Q, Gao L. Ma C, et al. Among authors: du y. Evid Based Complement Alternat Med. 2021 Mar 3;2021:6661667. doi: 10.1155/2021/6661667. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33747110 Free PMC article.

5

The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis.

Ma C, Yan K, Wang Z, Zhang Q, Gao L, Xu T, Sai J, Cheng F, Du Y. Ma C, et al. Among authors: du y. Bioengineered. 2021 Dec;12(1):2187-2202. doi: 10.1080/21655979.2021.1933302. Bioengineered. 2021. PMID: 34096467 Free PMC article.

6

The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats.

Hou W, Hao Y, Yang W, Tian T, Fang P, Du Y, Gao L, Gao Y, Zhang Q. Hou W, et al. Among authors: du y. Drug Des Devel Ther. 2021 Sep 8;15:3845-3862. doi: 10.2147/DDDT.S308713. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34526765 Free PMC article.

7

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs.

Liang J, Wei X, Hou W, Wang H, Zhang Q, Gao Y, Du Y. Liang J, et al. Among authors: du y. Sci Rep. 2022 Aug 18;12(1):14052. doi: 10.1038/s41598-022-18396-1. Sci Rep. 2022. PMID: 35982134 Free PMC article.

8

Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle.

Liang J, Wei X, Hou W, Wang H, Ma R, Gao Y, Du Y, Zhang Q. Liang J, et al. Among authors: du y. Chin Med. 2023 Nov 30;18(1):157. doi: 10.1186/s13020-023-00858-x. Chin Med. 2023. PMID: 38037150 Free PMC article.

9

PANoptosis-like death in acute-on-chronic liver failure injury.

Ye Q, Wang H, Chen Y, Zheng Y, Du Y, Ma C, Zhang Q. Ye Q, et al. Among authors: du y. Sci Rep. 2024 Jan 3;14(1):392. doi: 10.1038/s41598-023-50720-1. Sci Rep. 2024. PMID: 38172209 Free PMC article.

10

Effects of Xiaoke granule on transforming growth factor-beta1 expression and proliferation in rat mesangial cells.

Ji XM, Wang Q, Gong MX, Du YQ, Jia DX. Ji XM, et al. Chin Med J (Engl). 2006 Nov 5;119(21):1839-42. Chin Med J (Engl). 2006. PMID: 17097041 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,392 results

Search Page

Filters